These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 12444298

  • 21. Phosphorylation of enkephalins enhances their proteolytic stability.
    Dass C, Mahalakshmi P.
    Life Sci; 1996; 58(13):1039-45. PubMed ID: 8622556
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of leucine enkephalin metabolism in rat blood, plasma and tissues in vitro by an aminoboronic acid derivative.
    Hussain MA, Rowe SM, Shenvi AB, Aungst BJ.
    Drug Metab Dispos; 1990; 18(3):288-91. PubMed ID: 2143133
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of leu-enkephalin binding by neuroleptics.
    Somoza E, Bazán E, Galindo A.
    Neuropsychobiology; 1982; 8(6):297-303. PubMed ID: 6131391
    [Abstract] [Full Text] [Related]

  • 24. Enkephalin degradation in the guinea-pig ileum: effect of aminopeptidase inhibitors, puromycin and bestatin.
    Cohen ML, Geary LE, Wiley KS.
    J Pharmacol Exp Ther; 1983 Feb; 224(2):379-85. PubMed ID: 6822962
    [Abstract] [Full Text] [Related]

  • 25. [The effect of the aminopeptidase inhibitor bestatin on the enkephalin level in the rat brain].
    Beliaev NA, Kolesanova EF, Kelesheva LF, Rotanova TV, Panchenko LF.
    Biull Eksp Biol Med; 1990 Nov; 110(11):474-5. PubMed ID: 2083325
    [Abstract] [Full Text] [Related]

  • 26. Effects of Phenothiazines on Aldehyde Oxidase Activity Towards Aldehydes and N-Heterocycles: an In Vitro and In Silico Study.
    Deris-Abdolahpour F, Abdolalipouran-Sadegh L, Dastmalchi S, Hamzeh-Mivehroud M, Zarei O, Dehgan G, Rashidi MR.
    Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):275-286. PubMed ID: 30382490
    [Abstract] [Full Text] [Related]

  • 27. Antagonistic activity of some phenothiazine derivatives against neurohumoral transmitters.
    Saxena PN, Johri MB.
    Jpn J Pharmacol; 1973 Jun; 23(3):363-71. PubMed ID: 4146777
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Inhibitory effect of antipsychotic drugs on the Con A- and LPS-induced proliferative activity of mouse splenocytes: a possible mechanism of action.
    Basta-Kaim A, Budziszewska B, Jagła G, Nowak W, Kubera M, Lasoń W.
    J Physiol Pharmacol; 2006 Jun; 57(2):247-64. PubMed ID: 16845229
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pulmonary metabolism of exogenous enkephalins in isolated perfused rat lungs.
    Gillespie MN, Krechniak JW, Crooks PA, Altiere RJ, Olson JW.
    J Pharmacol Exp Ther; 1985 Mar; 232(3):675-81. PubMed ID: 2983067
    [Abstract] [Full Text] [Related]

  • 32. Inactivation of enkephalin by brain enzymes.
    Vogel Z, Altstein M.
    Prog Biochem Pharmacol; 1980 Mar; 16():49-59. PubMed ID: 7003599
    [Abstract] [Full Text] [Related]

  • 33. Novel non-neuroleptic phenothiazines inhibit Mycobacterium tuberculosis replication.
    Salie S, Hsu NJ, Semenya D, Jardine A, Jacobs M.
    J Antimicrob Chemother; 2014 Jun; 69(6):1551-8. PubMed ID: 24569630
    [Abstract] [Full Text] [Related]

  • 34. Plasma level monitoring of antipsychotic drugs. Clinical utility.
    Dahl SG.
    Clin Pharmacokinet; 1986 Jun; 11(1):36-61. PubMed ID: 2868820
    [Abstract] [Full Text] [Related]

  • 35. Induced formation of phenylalanine ammonia lyase and pisatin by chlorpromazine and other phenothiazine derivatives.
    Hadwiger LA, Martin AR.
    Biochem Pharmacol; 1971 Dec; 20(12):3255-61. PubMed ID: 5167294
    [No Abstract] [Full Text] [Related]

  • 36. Studies of the in vitro human plasma degradation of methionine-enkephalin.
    Mosnaim AD, Puente J, Wolf ME, Callaghan OH, Busch R, Diamond S.
    Gen Pharmacol; 1988 Dec; 19(5):729-33. PubMed ID: 3215483
    [Abstract] [Full Text] [Related]

  • 37. Structure-antitubercular activity relationship of phenothiazine-type calmodulin antagonists.
    Ratnakar P, Rao SP, Sriramarao P, Murthy PS.
    Int Clin Psychopharmacol; 1995 Mar; 10(1):39-43. PubMed ID: 7622803
    [Abstract] [Full Text] [Related]

  • 38. LENTICULAR OPACITIES WITH PROLONGED PHENOTHIAZINE THERAPY: A POTENTIAL HAZARD WITH ALL PHENOTHIAZINE DERIVATIVES.
    MARGOLIS LH, GOBLE JL.
    JAMA; 1965 Jul 05; 193():7-9. PubMed ID: 14301605
    [No Abstract] [Full Text] [Related]

  • 39. A subset of N-substituted phenothiazines inhibits NADPH oxidases.
    Seredenina T, Chiriano G, Filippova A, Nayernia Z, Mahiout Z, Fioraso-Cartier L, Plastre O, Scapozza L, Krause KH, Jaquet V.
    Free Radic Biol Med; 2015 Sep 05; 86():239-49. PubMed ID: 26013584
    [Abstract] [Full Text] [Related]

  • 40. Plasma methionine-enkephalin and leucine-enkephalin in normal subjects and patients with pheochromocytoma.
    Yoshimasa T, Nakao K, Li S, Ikeda Y, Suda M, Sakamoto M, Imura H.
    J Clin Endocrinol Metab; 1983 Oct 05; 57(4):706-12. PubMed ID: 6885962
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.